Analysis of the clinical treatment effect of 116 imported falciparum malaria cases in Wuhan City
10.3969/j.issn.1006-2483.2022.02.030
- VernacularTitle:武汉市116例境外输入性恶性疟临床治疗效果分析
- Author:
Shukun YU
1
;
Huadong LI
2
;
Zhiyang TAO
1
;
Kai WU
3
Author Information
1. Wuhan Dongxihu District Center for Disease Control and Prevention , Wuhan , Hubei 430040 , Wuhan , China
2. Wuhan Jinyintan Hospital , Wuhan , Hubei 430040, China
3. Wuhan Centers for Disease Control and Prevention , Wuhan , Hubei 430015 , China
- Publication Type:Journal Article
- Keywords:
Falciparum malaria;
Artemisinin;
Artemisinin;
Therapeutic effect
- From:
Journal of Public Health and Preventive Medicine
2022;33(2):134-136
- CountryChina
- Language:Chinese
-
Abstract:
Objective To analyze and evaluate the clinical characteristics of imported falciparum malaria cases and the antimalarial effect of artemisinin-based drugs, to promote rational and standardized drug use, and to improve the clinical cure rate of falciparum malaria. Methods A total of 116 imported cases of falciparum malaria admitted to the provincial malaria designated hospital in Wuhan were collected, and the clinical characteristics of the patients and use of artemisinin, and the therapeutic effects of the artemisinin-based drugs were retrospectively analyzed. Results The clinical manifestations of imported falciparum malaria were complicated and varied and had many complications, including mainly fever, anorexia, anemia, and jaundice, etc. The symptoms were alleviated or disappeared after treatment with artemisinin, without obvious adverse drug reactions. The median time of fever reduction was 2 days, the median time of Plasmodium becoming negative was 3 days, and the median time of clinical symptom relief was 3 days. 109 cases of common falciparum malaria were treated by oral artemisinin compound or artesunate injection combined with oral artemisinin compound, including 30 cases of oral artemisinin compound treatment for 1 to 4 days (1 case relapsed) and 79 cases of artesunate injection combined with oral artemisinin compound for 4 to 6 days (4 cases relapsed). Seven severe cases were cured after long-term and high-dose treatment with artesunate injection combined with oral multiple artemisinin compounds, and the total cure rate was 95.69% (111/116). Conclusion The present study demonstrates that the treatment of falciparum malaria by oral injection of artemisinin is safe and effective, and the cure rate is high. However, some patients have recurrence of the malaria parasite after stopping artemisinin drugs. It is necessary to ensure the use of artemisinin-based drugs in a “standardized, full-process, and adequate” way to contain the risk of severe illness and drug resistance.
